Zionsville, IN, United States of America

Susan Marie Reutzel-Edens



 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Indianapolis, IN (US) (2003 - 2009)
  • Zionsville, IN (US) (2008 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Susan Marie Reutzel-Edens: Innovator in Pharmaceutical Advancements

Introduction

Susan Marie Reutzel-Edens is a distinguished inventor based in Zionsville, Indiana, with a notable portfolio of seven patents. Her work primarily focuses on innovative pharmaceutical compounds that aim to address critical health issues, particularly diabetes and cancer. Her contributions to the field are framed within her role at Eli Lilly and Company, a leading global pharmaceuticals company.

Latest Patents

Among her latest inventions is the patent for a compound formulated as 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}-5-(propan-2-yl)-1H-pyrazol-3-yl beta-D glucopyranoside acetate. This compound illustrates her commitment to developing treatments for diabetes. Additionally, she has invented a crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride. This invention focuses on cancer treatment and includes methods for inhibiting tumor growth using the compound.

Career Highlights

As an accomplished inventor, Reutzel-Edens has established herself as a vital asset in the field of pharmaceutical research and development. Her work at Eli Lilly and Company has positioned her at the forefront of innovations aimed at improving patient outcomes through enhanced therapeutic interventions.

Collaborations

Throughout her career, Susan has collaborated with prominent colleagues, including Julie Kay Bush and Erik Christopher Chelius. These partnerships highlight the importance of teamwork in driving successful innovations and developing comprehensive solutions in the pharmaceutical industry.

Conclusion

Susan Marie Reutzel-Edens continues to contribute to the advancement of medical science through her innovative inventions. Her dedication to improving health outcomes showcases the impact of her work on the treatment of significant health challenges such as diabetes and cancer, setting a precedent for current and future inventors in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…